MyWealthGrowth.com logo
HomeMutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund

Regular PlanGrowth Option

Fund Performance

Lumpsum

SIP

14.91

as on 22 Sep 2023

3 Years

Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 15,171 today.

Invest Now

NAV Performance

Nippon India Pharma Fund performance graph for last 3 years
Performance of Nippon India Pharma Fund for last 3 Years

Fund Information

  • ₹ 343.407

    as on 22 Sep 2023
  • Regular - Growth

  • -

  • ₹ 5,000

  • ₹ 4,304 Cr.

    as on 31 May 2023
  • 1.98%

  • 02 Jan 2013

  • Equity - Sectoral/Thematic

  • S&P BSE Healthcare TRI

  • Nippon India Mutual Fund

    Show All Funds
  • Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Highlights of this fund

Nippon India Pharma Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 02 Jan 2013. This fund is offered by one of the top AMC (Assets Management Company) Nippon India Mutual Fund. You can also view here all other Equity funds offered by Nippon India Mutual Fund.

Latest NAV of the fund is ₹ 343.407 as on 22 Sep 2023.

This fund has 10 years of track record. Since 31 Mar 2023 expense ratio of this fund is 1.98%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.

You can invest in this fund in SIP with the minimum investment of ₹ 100. Lumpsum invest is offered with minimum investment of ₹ 5,000.

Fund Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

List of Fund Managers of Nippon India Pharma Fund

  • About Kinjal Desai

    Picture of Kinjal DesaiKinjal Desai is Fund Manager – Overseas at Reliance Mutual Fund. Kinjal has obtained her Masters in Economics from Warwick University, UK. She has a total experience of 6 years as Research Analyst – Equities at Reliance Mutual Fund where she started her career as an Associate.
  • About Sailesh Raj Bhan

    Picture of Sailesh Raj BhanMr. Sailesh Raj Bhan has over 24 years of experience in Indian Equity Markets with over 15 years at Reliance Nippon Life Asset Management Limited in Fund Management. He manages the flagship diversified equity schemes like Reliance Multi Cap Fund (previously Reliance Equity Opportunities Fund) - a strategy with assets of over Rs10,000cr ($1.5bn) since its inception in March 2005 and Reliance Large Cap Fund (previously Reliance Top200 Fund) – with assets of over Rs13000cr (over $1.8bn) since its inception 2007. Sailesh also manages the Largest Pharma Sector Fund in India since its inception 15 years back in May 2004, in addition to managing Reliance Consumption Fund – a broad based Consumption Thematic product since 2004. He also advises on international mandates for some strategies for the last 5 years.
  • About Akshay Sharma

    Picture of Akshay Sharma

Riskometer : Risk associated with this fund

Investors understand that their principal will be at Very High Risk

Fund Return Comparison

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 9.55% 21.62% 36.88% 38.44% 38.01% 45.43% 25.50% 23.54% 54.23% 37.48% 35.76% 31.74% 21.08%
Category Average 2.36% 8.61% 21.90% 18.64% 11.18% 26.15% 14.79% 16.12% 29.66% 19.34% 19.65% 20.24% 15.17%
Nippon India Pharma Fund -1.69%₹ 9,831 11.58%₹ 11,157 28.39%₹ 12,838 24.62%₹ 12,462 35.61%₹ 14,205 4.73%₹ 10,967 18.17%₹ 28,692 14.91%₹ 15,171 14.41%₹ 44,607 16.23%₹ 21,230 19.57%₹ 97,689 16.85%₹ 47,551 15.29%₹ 2,67,246
ICICI Prudential Infrastructure Fund 2.81%₹ 10,280 11.08%₹ 11,108 23.08%₹ 12,307 32.75%₹ 13,274 39.12%₹ 14,411 26.00%₹ 15,877 32.76%₹ 32,673 45.43%₹ 30,755 35.60%₹ 59,589 20.29%₹ 25,210 29.95%₹ 1,25,327 18.09%₹ 52,834 18.33%₹ 3,14,802
Quant Infrastructure Fund 2.30%₹ 10,230 9.81%₹ 10,981 18.67%₹ 11,867 8.03%₹ 10,803 20.00%₹ 13,262 16.67%₹ 13,610 17.05%₹ 28,394 43.33%₹ 29,443 26.71%₹ 52,953 25.50%₹ 31,169 31.74%₹ 1,30,741 21.69%₹ 71,350 21.06%₹ 3,64,761
ICICI Prudential Commodities Fund 1.98%₹ 10,198 7.45%₹ 10,745 16.64%₹ 11,663 19.43%₹ 11,943 25.48%₹ 13,597 12.70%₹ 12,700 19.86%₹ 29,143 43.14%₹ 29,325 26.25%₹ 52,621 - - - -
HDFC Infrastructure Fund 2.35%₹ 10,234 16.17%₹ 11,617 36.88%₹ 13,687 35.71%₹ 13,570 54.23%₹ 15,288 25.81%₹ 15,828 37.33%₹ 33,960 42.53%₹ 28,957 35.76%₹ 59,718 13.68%₹ 19,000 26.31%₹ 1,14,946 14.76%₹ 39,670 13.37%₹ 2,41,097
DSP India T.I.G.E.R. Fund 1.58%₹ 10,158 13.53%₹ 11,352 30.43%₹ 13,043 30.69%₹ 13,068 45.92%₹ 14,809 21.64%₹ 14,796 32.20%₹ 32,517 41.54%₹ 28,358 32.56%₹ 57,259 19.34%₹ 24,232 27.62%₹ 1,18,602 18.83%₹ 56,263 17.83%₹ 3,06,373

Portfolio Holdings

Portfolio holdings pattern of Nippon India Pharma Fund as on 23 Sep 2023 are listed below:

  • Equity Holdings:

    97.95%
  • Debt Holdings:

    0.00%
  • Others Holdings:

    2.05%

Top Sector Holdings of Nippon India Pharma Fund

Name of SectorHolding PercentageHolding Values in Crore
Pharmaceuticals 74.43% ₹ 3,397.31 Cr.
Hospital 14.86% ₹ 678.32 Cr.
Healthcare service providers 4.98% ₹ 227.49 Cr.
Speciality retail 3.41% ₹ 155.62 Cr.
Medical equipment & supplies 0.27% ₹ 12.41 Cr.
Others 2.05% -

Top Stock Holdings of Nippon India Pharma Fund

Name of StocksHolding PercentageHolding Values in Crore
Sun Pharmaceutical Industries Ltd. 14.01% ₹ 639.47 Cr.
Lupin Ltd. 7.06% ₹ 322.10 Cr.
Cipla Ltd. 6.26% ₹ 285.92 Cr.
Dr. Reddys Laboratories Ltd. 5.42% ₹ 247.57 Cr.
Divis Laboratories Ltd. 5.29% ₹ 241.33 Cr.
Others 61.96% -

Other Holdings

Holding TypeHolding Percentage
Net Receivables 1.56%
TREPS 0.49%
Margin 0.00%